http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0204437-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34a985903600988a5bd119d8306f1728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_131755aaf05551f0418275c7362905b7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
filingDate 2001-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3223f8740c5aa928025ef1f40f8eabda
publicationDate 2002-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0204437-A1
titleOfInvention Obesity inhibitory materials
abstract Obesity inhibitory materials which are absorbed in the body via oral administration or dripping and affect causes of overeating. Thus, they can regulate food intake and thus promote the metabolism of lipids and inhibit the accumulation of body fat without suppressing immune functions. At the same time, they can inhibit an increase in blood pressure, thereby surely inhibiting body weight gain (obesity). Such obesity inhibitory materials have never been reported hitherto. These obesity inhibitory materials having the above-described excellent effects are largely characterized by containing isoflavone aglycons and/or isoflavone glycosides.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007314438-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7265904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009280517-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1623707-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020074728-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2004045603-A1
priorityDate 2000-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11228430-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0829261-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11243928-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000281673-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08134091-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127983340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399303

Total number of triples: 35.